Intravesical Nanocrystalline Silver Decreases Experimental Bladder Inflammation
is companion of
Abstract
Purpose:
Interstitial cystitis is a sterile bladder inflammatory disease characterized by pelvic pain, urinary urgency and frequency. Nanocrystalline silver has anti-inflammatory properties, prompting us to investigate its effect in experimental bladder inflammation.
Materials and Methods:
Nanocrystalline silver (0.01%, 0.05%, 0.1%, 0.5% or 1%) or phosphate buffered saline (Invitrogen™) (0.5 ml) was introduced intravesically in Sprague-Dawley female rat (Charles River Laboratories, Wilmington, Massachusetts) bladders for 20 minutes, followed by vehicle or protamine sulfate (10 mg/ml for 30 minutes) and lipopolysaccharide (Sigma®) (2 mg/ml for 45 minutes). Urine was collected throughout for histamine assay. The catheter was removed, the rat was returned to its cage and 4 hours later it was sacrificed. The bladder was harvested, minced and cultured overnight. The medium was collected for tumor necrosis factor-α assay.
Results:
Mean ± SD total urine histamine increased from 270 ± 190 ng in 4 controls to 842 ± 239 ng after protamine sulfate/lipopolysaccharide and it decreased to 505 ± 187 ng in 6 animals after pretreatment with 1% nanocrystalline silver (p = 0.036). Tumor necrosis factor-α release in explant medium increased from 0.02 ± 0.03 pg/mg in 6 controls to 0.28 ± 0.15 pg/mg in 14 animals after treatment with protamine sulfate/lipopolysaccharide and it decreased to 0.12 ± 0.11 pg/mg in 10 animals pretreated with nanocrystalline silver (p = 0.009). Nanocrystalline silver was not effective at less than 1% and at 1% alone it released 0.05 ± 0.07 pg/mg tumor necrosis factor-α in 7 rats (vs phosphate buffered saline in 6, p = 0.387). Nanocrystalline silver (1%) significantly decreased bladder inflammation and mast cell activation. These effects were apparent even 4 days later.
Conclusions:
Intravesical administration of nanocrystalline silver (1%) decreased urine histamine, bladder tumor necrosis factor-α and mast cell activation without any toxic effect. This action may be useful for interstitial cystitis.
References
- 1 :
Painful bladder syndrome . In: Campbell-Walsh Urology. Edited by . Philadelphia: WB Saunders2007: 330. Google Scholar - 2 : Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol2006; 51: 809. Google Scholar
- 3 : Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol2005; 174: 2231. Link, Google Scholar
- 4 : Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin Urol1991; 9: 124. Google Scholar
- 5 : Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs2007; 67: 215. Google Scholar
- 6 : Immunomodulators for the treatment of interstitial cystitis. Urology2005; 65: 633. Google Scholar
- 7 : Inflammatory cell types and clinical features of interstitial cystitis. Urology1997; 158: 790. Abstract, Google Scholar
- 8 : Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology2001; 57: 47. Google Scholar
- 9 : Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology2001; 57: 67. Google Scholar
- 10 : Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol2005; 152: 1235. Google Scholar
- 11 : Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen2002; 10: 141. Google Scholar
- 12 : Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin. J Urol1996; 155: 1133. Link, Google Scholar
- 13 : Protamine sulfate-induced cystitis: a model of selective cytodestruction of the urothelium. Urology2001; 57: 113. Google Scholar
- 14 : Novel duplex antimicrobial silver films deposited by magnetic sputtering. Philos Mag Lett2000; 80: 249. Google Scholar
- 15 : Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation. J Urol2006; 177: 1186. Google Scholar
- 16 : Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J Urol2005; 173: 630. Link, Google Scholar
- 17 : Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control1999; 27: 344. Google Scholar
- 18 : Mast cells mediate the severity of experimental cystitis in mice. J Urol1999; 162: 231. Link, Google Scholar
- 19 : Evidence for urothelial cell activation in interstitial cystitis. Urology1993; 149: 470. Abstract, Google Scholar
- 20 : Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol2004; 146: 1. Google Scholar
